Category: Immunotherapy

Home / Established Year

Utilizing Immunotherapy to Treat Late-Stage Cancers

Utilizing Immunotherapy to Treat Late-Stage Cancers

  Introduction Immunotherapy has become a groundbreaking method in cancer treatment, especially for advanced-stage cancer treatments that have demonstrated minimal effectiveness with standard medicines. This innovative appr..

Tumor Infiltrating Lymphocyte (TIL) therapy in China

Tumor-Infiltrating Lymphocyte (TIL) Therapy in China

Feb 2024: Tumor-infiltrating lymphocyte (TIL) therapy treatment is a potential method that utilizes the body's immune system to fight solid tumors. This therapeutic area in China is advancing rapidly because of the nation's incr..

Free Cancer Treatment In China For Those Who Can’t Afford It

Free Cancer Treatment In China Without Breaking The Bank: A Guide For Those Who Need It Most

Free cancer treatment in China is providing hope and healing to people in need. So, if you are unable to opt for cancer treatment because of its extensive cost, this guide is specially meant for you. Find out how reputed organiz..

The Role Of Immunotherapy In Lymphoma Treatment

The Role Of Immunotherapy In Lymphoma Treatment

If you're reading this, you or maybe one of your loved ones is on a journey that no one ever plans to take—the path of facing cancer. We understand that this road is filled with uncertainties, fears, and moments when it feel..

Tumor Infiltrating Lymphocytes (TIL) Immunotherapy is a promising approach in the field of cancer treatment
, ,

Tumor Infiltrating lymphocytes (TIL) Immunotherapy in India

April 2023: Using the body's immune system to fight cancer cells is the goal of the promising cancer treatment method known as tumour infiltrating lymphocytes (TIL) immunotherapy. The process entails taking immune cells called TI..

jw-therapeutics
, , , ,

JW Therapeutics Presents Latest Clinical Data on Carteyva® in Follicular Lymphoma and Mantle Cell Lymphoma at the 64th ASH Annual Meeting

SHANGHAI, CHINA, December 12, 2022 An independent and creative biotechnology company called JW Therapeutics (HKEX: 2126) focuses on developing, manufacturing, and selling cell immunotherapy products. At the 64th American Society ..

jw-therapeutics
, , ,

JW Therapeutics Announces That Its Cell Immunotherapy Drugs Have Successfully Benefited 300 Patients

SHANGHAI, CHINA, November 9, 2022 - JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing, and commercializing cell immunotherapy products, announced that as of N..

jw-therapeutics
, , , ,

JW Therapeutics and 2seventy bio Announce Strategic Partnership to Accelerate the Research and Development of T-cell-based Immunotherapies

SHANGHAI, CHINA and CAMBRIDGE, MASSACHUSETTS, US, October 27, 2022 - JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing, and commercializing cell immunotherap..

, , , ,

Pembrolizumab is approved for advanced endometrial carcinoma

April 2022: Pembrolizumab (Keytruda, Merck) was approved by the Food and Drug Administration as a single agent for patients with advanced endometrial carcinoma that is microsatellite instability-high (MSI-H) or mismatch repair de..

PD-1 inhibitor immunotherapy for B cell lymphoma

A review written by Young, MD, Anderson Cancer Center, USA explained the application of PD-1 inhibitor immunotherapy in B-cell lymphoma. (Blood. Online version on November 8, 2017. doi: 10.1182 / blood-2017-07-740993.)PD-1 immune..

Newer
Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy